Thomas Jensen

PhD fellow, Department of Cardiology, Aarhus University Hospital @AUHCardio @AarhusUni

[SABOURETCardiologist @SABOURETCardio]

What a good surprise for #Christmas ! ☀️🎄☀️ our article is online with FREE access thanks to @LeonOuazana and @CNCFCardio #SAPT #DAPT #CardioTwitter

[Thomas Jensen @thjendk]

Read our newest paper in the European Heart Journal - Cardiovascular Pharmacotherapy👇

We show that cessation of antiplatelet therapy is safe and effective beyond 1 year after PCI in patients with atrial fibrillation https://t.co/qz8VROjo5f @AgewallStefan @AUHCardio

[Anders Kramer @Anders_K_H]

Standardization and a common nomenclature for #yesCCT findings following #LAAO is needed for both research and training purposes! We propose a novel algorithm for interpretation of hypoattenuated thickening (HAT) on the #Watchman FLX.
@AUHCardio
https://t.co/CWxCEbfFLR

[Mattia Galli @MattiaGalli10]

Real world data supporting the use of long-term OAC monotherapy (without an antiplatelet agent) beyond 1 year after PCI in patients with atrial fibrillation. #ehjcvp
https://t.co/lzjh60ty8I

[SABOURETCardiologist @SABOURETCardio]

Antithrombotic treatment beyond one year after #PCI in patients with #AF . New data after the RCT #AFIRE https://t.co/S3ekee3UO8

[Thomas Jensen @thjendk]

Read our newest study in @EJCI_News!🎉 https://t.co/4xtQiLhnFf
Guideline implementation of the CHA2DS2-VASC score was associated with increased use of triple therapy and a decline in ischemic outcomes. Paradoxically, risk of bleeding remained constant @AUHCardio @michael_maeng

[Anders Kramer @Anders_K_H]

#LAAO is an attractive alternative in cases of concurrent AFib and haemophilia. Close collaboration between cardiovascular and haematological specialists can provide a safe and feasible approach! @KasperKorsholm @Nielsen_Kudsk @AUHCardio @JICE_EP
https://t.co/ATD8bT3Rfm

[Department of Cardiology Research AUH @AUHCardio]

A huge thank to @DCAcademyDK for two phenomenal days at “Empower Your Talent” course in Aarhus! The days included motivational and inspiring talks and networking with fellow #cardiovasular researchers 🫀

[Thomas Jensen @thjendk]

Today, at the annual Research Meeting for the Institute of Clinical Medicine, we are presenting our work on long-term anticoagulatory therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. If you are at AUH, come say hi! @AUHCardio @AarhusUni

[Tanja Charlotte Frederiksen @TanjaCharlotteF]

I had two inspiring days in great company with fellow researchers in #cardiovascular disease @DCAcademyDK

Very proud to be a part of this visionary community 🌟

@DFyenbo @omeedneghabat @LNAndreasen @thjendk @AnneKaltoft @aalkjaer @etbrondum @FinnGustafsson @MortenAlbaek